Stock Analysts

Northrop Wins Defense Contract of $93.1M for Spy Drones

Defense contractor Northrop Grumman Corporation NOC won a contract from the U.S. Defense Advanced Research Projects Agency (“DARPA”) for the Tactically Exploited Reconnaissance Node (Tern) program, Phase III, worth $93.1 million. Per the contract, Northrop will manufacture a medium-altitude, full-scale demonstrator of a new unmanned spy drone with a flying wing having large counter-rotating propellers, which will be able to take off from and land on destroyers and frigates […]

Stock Analysts

Sanofi Seeks FDA Approval for Diabetes Drug Combination

Updates on the regulatory front are eagerly awaited by investors in the pharma/ biotech sector as they impact the share price of the concerned company. Regulatory updates include events like filing of marketing applications, acceptance of these applications for review by the regulatory agencies, reviews by advisory panels and, finally, a response from the regulatory agency regarding the approval status. Last week, Sanofi SNY announced that it has filed a new drug application (NDA) with the FDA for the fixed-ratio combination of its diabetes drugs, Lantus (insulin glargine, 100 units/mL) and Lyxumia (lixisenatide). […]

Stock Analysts

GW Pharmaceuticals Publishes Encouraging Epidiolex Data

GW Pharmaceuticals plc GWPH announced that data on its cannabidiol-based drug, Epidiolex, from the physician-led expanded access program in treatment-resistant epilepsy were published in The Lancet Neurology . As per the published paper, Epidiolex reduced seizure frequency across multiple drug-resistant epilepsy syndromes and seizure types, and administration of Epidiolex as an add-on treatment led to a clinically meaningful reduction in seizure frequency in many patients. […]

Stock Analysts

3 Reasons to Add CoreSite Realty (COR) to Your Portfolio

Despite the Fed lift-off this month, we believe that adding CoreSite Realty Corporation COR to your investment portfolio is a good idea right now. Coresite Realty provides data center products and interconnection services to telecommunication carriers, content and media entertainment providers, cloud providers, enterprise customers, financial and educational institutions, and government agencies. Notably, shares of this Denver, CO-based REIT gained over 49% year to date […]

Stock Analysts

Will Bemis Keep Suffering from Unfavorable Foreign Currency?

On Dec 24, 2015, we issued an updated research report on Bemis Company, Inc. BMS , a global manufacturer of flexible packaging products and pressure sensitive materials that are sold primarily to the food industry. Bemis’ third-quarter 2015 adjusted earnings rose 9.8% year over year led by continued progress in the implementation of long-term strategies and strong operational performance […]

Stock Analysts

General Electric’s Funds to Boost Food & Beverage Market

Premium diversified machinery firm General Electric Company’s GE financial unit, GE Capital, recently declared its decision to act as the primary provider of a $180-million secured credit facility for a Chicago, IL-based beverage & food company, Arbor Investments. The company would utilize the funds to acquire majority stake in DPI Specialty Foods, Inc. (‘DPI’) […]

Stock Analysts

Novartis Reveals Positive Data on Spondylitis Drug Cosentyx

Investors in the pharma/biotech sector eagerly wait for pipeline updates as they play an important role in deciding whether or not to invest in a particular company. These updates provide information on experimental drugs and at times give an insight on the commercial potential of the candidate once it is successfully developed and commercialized. Novartis NVS announced encouraging results from two phase III studies (MEASURE 1 and MEASURE 2) on Cosentyx (secukinumab) for the indication of ankylosing spondylitis (AS) […]

Stock Analysts

Exelixis Submits Rolling NDA for Oncology Drug in the U.S.

Investors in the pharma/biotech sector eagerly wait for pipeline updates as they play an important role in deciding whether or not to invest in a particular company. These updates provide information on experimental drugs and at times give an insight on the commercial potential of the candidate once it is successfully developed and commercialized. […]

Stock Analysts

FelCor (FCH) Seeks to Create Value with Asset Disposition

Recently, FelCor Lodging Trust Incorporated FCH has been aiming to increase its shareholders’ value by disposition of assets. In fact, in CEO Spotlight video interview at REITWorld 2015: NAREIT’s Annual Convention for All Things REIT at the Wynn Las Vegas, published in reit.com, Richard Smith, president and CEO of FelCor, explained the company’s asset disposition strategy. The Irving, TX-based real estate investment trust’s (“REIT”) goal is to improve capacity and utilize the sale proceeds for other high-yielding assets. […]